期刊的影响因子--文章列表

期刊文章列表
Yu Han，Yu Zhang，Kelan Yuan，Yaying Wu，Xiuming Jin，Xiaodan Huang（Eye Center，The Second Affiliated Hospital，Zhejiang University School of Medicine，Zhejiang Provincial Key Laboratory of Ophthalmology，Zhejiang Provincial Clinical Research Center for Eye Diseases，Zhejiang Provincial Engineering Institute on Eye Diseases）.Hyperosmolarity promotes macrophage pyroptosis by driving the glycolytic reprogramming of corneal epithelial cells in dry eye disease[J].Frontiers of Medicine,2023,第4期 Jiaqi Dai^1,2，Tao Wang³，Ke Xu^1,2，Yang Sun^1,2，Zongzhe Li^1,2，Peng Chen^1,2，Hong Wang²，Dongyang Wu²，Yanghui Chen²，Lei Xiao²，Hao Liu²，Haoran Wei²，Rui Li^1,2，Liyuan Peng¹，Ting Yu¹，Yan Wang^1,2，Zhongsheng Sun³，Dao Wen Wang^1,2（Division of Cardiology Department of Internal Medicine，Tongji Hospital，Tongji Medical College，Huazhong University of Science and Technology；Hubei Key Laboratory of Genetics and Molecular Mechanism of Cardiologic Disorders，Huazhong University of Science and Technology；Beijing Institutes of Life Science，Chinese Academy of Sciences）.Machine learning modeling identifies hypertrophic cardiomyopathy subtypes with genetic signature[J].Frontiers of Medicine,2023,第4期 Zheng Jin^1,2,3,4，Qin Zhou^1,2,5，Jia-Nan Cheng^1,2，Qingzhu Jia^1,2，Bo Zhu^1,2（Department of Oncology，Xinqiao Hospital，Army Medical University；Key Laboratory of Tumor Immunotherapy；Research Institute，GloriousMed Clinical Laboratory (Shanghai) Co.Ltd.；Institute of Life Sciences，Chongqing Medical University；School of Pharmacy and Bioengineering，Chongqing University of Technology）.Heterogeneity of the tumor immune microenvironment and clinical interventions[J].Frontiers of Medicine,2023,第4期 Yarui Ma¹，Jingbo Gan²，Yinlei Bai²，Dandan Cao²，Yuchen Jiao¹（State Key Laboratory of Molecular Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Genetron Health (Beijing) Co.Ltd.）.Minimal residual disease in solid tumors：an overview[J].Frontiers of Medicine,2023,第4期 Wenle Ye^1,2，Jinghan Wang^1,2，Jiansong Huang^1,2，Xiao He³，Zhixin Ma⁴，Xia Li^1,2，Xin Huang^1,2，Fenglin Li^1,2，Shujuan Huang^1,2，Jiajia Pan^1,2，Jingrui Jin^1,2，Qing Ling^1,2，Yungui Wang^1,2，Yongping Yu⁵，Jie Sun^1,2，Jie Jin^1,2,6（Department of Hematology，The First Affiliated Hospital，Zhejiang University College of Medicine；Key Laboratory of Hematopoietic Malignancies，Diagnosis and Treatment；Research Centre，Centre hospitalier de l'Université de Montréal (CRCHUM)；Women's Hospital，School of Medicine，Zhejiang University；Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；Cancer Center，Zhejiang University）.ACSL5,a prognostic factor in acute myeloid leukemia,modulates the activity of Wnt/β-catenin signaling by palmitoylation modification[J].Frontiers of Medicine,2023,第4期 Zixun Yan¹，Li Li^1,2，Di Fu¹，Wen Wu¹，Niu Qiao¹，Yaohui Huang¹，Lu Jiang¹，Depei Wu³，Yu Hu⁴，Huilai Zhang⁵，Pengpeng Xu¹，Shu Cheng¹，Li Wang¹，Sahin Lacin²，Muharrem Muftuoglu²，Weili Zhao^1,6（Shanghai Institute of Hematology，State Key Laboratory of Medical Genomics，National Research Center for Translational Medicine at Shanghai，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；University of Texas MD Anderson Cancer Center；Institute of Hematology，The First Affiliated Hospital of Soochow University；Institute of Hematology，Union Hospital，Tongji Medical College，Huazhong University of Science and Technology；Tianjin Medical University Cancer Institute & Hospital；P?le de Recherches Sino-Fran?ais en Science du Vivant et Génomique，Laboratory of Molecular Pathology）.Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy[J].Frontiers of Medicine,2023,第4期 Tianzhuo Wang^1,2,3，Huiying Guo^1,2,3，Lei Zhang^1,2,3，Miao Yu^1,2,3，Qianchen Li^1,2,3，Jing Zhang^1,2,3，Yan Tang^1,2,3，Hongquan Zhang^1,2,3，Jun Zhan^1,2,3（Program for Cancer and Cell Biology，Department of Human Anatomy，Histology and Embryology School of Basic Medical Sciences；Peking University International Cancer Institute；MOE Key Laboratory of Carcinogenesis and Translational Research and State Key Laboratory of Natural and Biomimetic Drugs，Peking University Health Science Center）.FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progression[J].Frontiers of Medicine,2023,第4期 Zhiqin Zhang，Xinli Shi，Jingmin Ji，Yinglin Guo，Qing Peng，Liyuan Hao，Yu Xue，Yiwei Liu，Caige Li，Junlan Lu，Kun Yu（Department of Pathobiology and Immunology Hebei University of Chinese Medicine）.Dihydroartemisinin increased the abundance of Akkermansia muciniphila by YAP1 depression that sensitizes hepatocellular carcinoma to anti-PD-1 immunotherapy[J].Frontiers of Medicine,2023,第4期 Min Yan^1,2,3，Quentin Liu^1,2,3,4（Sun Yat-sen University Cancer Center；State Key Laboratory of Oncology in South China；Collaborative Innovation Center for Cancer Medicine；Institute of Cancer Stem Cell，Cancer Center，Dalian Medical University）.The nature of cancer[J].Frontiers of Medicine,2023,第4期 Chaoyue Xiao¹，Wei Xiong²，Yiting Xu³，Ji'an Zou³，Yue Zeng¹，Junqi Liu¹，Yurong Peng¹，Chunhong Hu^1,4，Fang Wu^1,4,5,6（Department of Oncology，The Second Xiangya Hospital，Central South University；NHC Key Laboratory of Carcinogenesis and Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education，Cancer Research Institute，Central South University；Xiangya School of Medicine，Central South University；Hunan Cancer Mega-Data Intelligent Application and Engineering Research Centre；Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer，The Second Xiangya Hospital，Central South University；Hunan Key Laboratory of Tumor Models and Individualized Medicine，The Second Xiangya Hospital，Central South University）.Immunometabolism：a new dimension in immunotherapy resistance[J].Frontiers of Medicine,2023,第4期 Dan Liu^1,2，Chunhui Xu³，Yanting Liu⁴，Wen Ouyang¹，Shaojian Lin⁴，Aining Xu¹，Yuanliang Zhang¹，Yinyin Xie¹，Qiuhua Huang¹，Weili Zhao¹，Zhu Chen¹，Lan Wang³，Saijuan Chen¹，Jinyan Huang^1,5，Zhe Bao Wu^4,6，Xiaojian Sun¹（Shanghai Institute of Hematology，State Key Laboratory of Medical Genomics，National Research Center for Translational Medicine at Shanghai，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；Key Laboratory of Systems Biomedicine，Ministry of Education，Shanghai Center for Systems Biomedicine，Shanghai Jiao Tong University；CAS Key Laboratory of Tissue Microenvironment and Tumor，Shanghai Institute of Nutrition and Health，Shanghai Institutes for Biological Sciences，University of Chinese Academy of Sciences，Chinese Academy of Sciences；Department of Neurosurgery，Center of Pituitary Tumor，Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine；Biomedical Big Data Center，First Affiliated Hospital，Zhejiang University School of Medicine，Cancer Center，Zhejiang University；Department of Neurosurgery，First Affiliated Hospital of Wenzhou Medical University）.A systematic survey of LU domain-containing proteins reveals a novel human gene,LY6A,which encodes the candidate ortholog of mouse Ly-6A/Sca-1 and is aberrantly expressed in pituitary tumors[J].Frontiers of Medicine,2023,第3期 Chengdong Wu^1,2,3,4,5,6，Dekai Liu^1,2,3,4,5,6，Lufei Zhang^1,2,3,4,5,6，Jingjie Wang^1,2,3,4,5,6，Yuan Ding^1,2,3,4,5,6，Zhongquan Sun^1,2,3,4,5,6，Weilin Wang^1,2,3,4,5,6（Department of Hepatobiliary and Pancreatic Surgery，The Second Affiliated Hospital，Zhejiang University School of Medicine；Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province；Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province；Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University；Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province；Cancer Center，Zhejiang University）.5'-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I[J].Frontiers of Medicine,2023,第3期 Ziyu Fu¹，Dongguo Liang¹，Wei Zhang^1,2，Dongling Shi³，Yuhua Ma⁴，Dong Wei⁵，Junxiang Xi¹，Sizhe Yang¹，Xiaoguang Xu¹，Di Tian³，Zhaoqing Zhu³，Mingquan Guo³，Lu Jiang¹，Shuting Yu¹，Shuai Wang¹，Fangyin Jiang¹，Yun Ling³，Shengyue Wang¹，Saijuan Chen¹，Feng Liu¹，Yun Tan¹，Xiaohong Fan³（Shanghai Institute of Hematology，National Research Center for Translational Medicine，State Key Laboratory of Medical Genomics，Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine；National Translational Science Center for Molecular Medicine & Department of Cell Biology，Fourth Military Medical University；Shanghai Public Health Clinical Center，Fudan University；Department of Nephrology，Traditional Chinese Medicine Hospital of KunShan；Department of Infectious Diseases，Ruijin Hospital Affiliated to Shanghai Jiao Tong University (SJTU) School of Medicine）.Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai[J].Frontiers of Medicine,2023,第3期 Yanhui Liang^1,2,3，Fangbing Chen^1,2,3,4，Kepin Wang^1,2,3,4，Liangxue Lai^1,2,3,4（China-New Zealand Joint Laboratory on Biomedicine and Health，CAS Key Laboratory of Regenerative Biology，Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine，Centre for Regenerative Medicine and Health，Hong Kong Institute of Science and Innovation，Guangzhou Institutes of Biomedicine and Health，Chinese Academy of Sciences；Research Unit of Generation of Large Animal Disease Models，Chinese Academy of Medical Sciences(2019RU015)；Sanya Institute of Swine Resource，Hainan Provincial Research Centre of Laboratory Animals；Guangdong Provincial Key Laboratory of Large Animal Models for Biomedicine，Wuyi University）.Base editors：development and applications in biomedicine[J].Frontiers of Medicine,2023,第3期 Pian Yu^1,2,3,4,5，Xiang Chen^1,2,3,4,5，Cong Peng^1,2,3,4,5（Department of Dermatology，Xiangya Hospital，Central South University；National Clinical Research Center for Geriatric Disorders，Xiangya Hospital；Hunan Key Laboratory of Skin Cancer and Psoriasis，Xiangya Hospital；Hunan Engineering Research Center of Skin Health and Disease，Xiangya Hospital；Xiangya Clinical Research Center for Cancer Immunotherapy，Central South University）.A new perspective in pyroptosis：lifting the veil on GSDMA activation[J].Frontiers of Medicine,2023,第3期 Wei Rao¹，Yutao Liu²，Yan Li¹，Lei Guo¹，Tian Qiu¹，Lin Dong¹，Jianming Ying¹，Weihua Li¹（Department of Pathology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Medical Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College）.Potential unreliability of ALK variant allele frequency in the efficacy prediction of targeted therapy in NSCLC[J].Frontiers of Medicine,2023,第3期 Mingyue Tan^1,2，Qi Pan¹，Qi Wu^1,3，Jianfa Li¹，Jun Wang^1,2,3（Department of Urology，Shanghai General Hospital，Shanghai Jiao Tong University School of Medicine；Urology Center，Shuguang Hospital，Shanghai University of Traditional Chinese Medicine；Department of Urology，The Sixth Affiliated Hospital of Wenzhou Medical University(The People's Hospital of Lishui)）.Aldolase B attenuates clear cell renal cell carcinoma progression by inhibiting CtBP2[J].Frontiers of Medicine,2023,第3期 Mengmeng Yin¹，Hongsheng Wang²，Xianmin Guan³，Ju Gao⁴，Minghua Yang⁵，Ningling Wang⁶，Tianfeng Liu⁷，Jingyan Tang⁸，Alex WK Leung⁹，Fen Zhou¹⁰，Xuedong Wu¹¹，Jie Huang¹²，Hong Li¹³，Shaoyan Hu¹⁴，Xin Tian¹⁵，Hua Jiang¹⁶，Jiaoyang Cai⁸，Xiaowen Zhai²，Shuhong Shen⁸，Qun Hu¹（Department of Pediatrics，Tongji Hospital of Tongji Medical College，Huazhong University of Science and Technology；Department of Hematology/Oncology，Children's Hospital of Fudan University；Department of Hematology/Oncology Chongqing Medical University Affiliated Children's Hospital；Department of Pediatrics，Key Laboratory of Birth Defects and Related Disease of Women and Children，Ministry of Education，West China Second University Hospital，Sichuan University；Department of Pediatrics，Xiangya Hospital Central South University；Department of Pediatrics，Anhui Medical University Second Affiliated Hospital；State Key Laboratory of Experimental Hematology and Division of Pediatric Blood Diseases Center，Institute of Hematology and Blood Diseases Hospital，Peking Union Medical College，Chinese Academy of Medical Sciences；Department of Hematology/Oncology，Shanghai Children's Medical Center，School of Medicine，Shanghai Jiao Tong University，Key Laboratory of Pediatric Hematology & Oncology of China Ministry of Health；Department of Pediatrics，Hong Kong Children's Hospital，The Chinese University of Hong Kong；Department of Pediatrics，Union Hospital of Tongji Medical College，Huazhong University of Science and Technology；Department of Pediatrics，Nanfang Hospital，Southern Medical University；Department of Hematology/Oncology，Children's Hospital of Nanjing Medical University；Department of Hematology/Oncology，Shanghai Children's Hospital，Shanghai Jiao Tong University；Department of Hematology/Oncology，Children's Hospital of Soochow University；Department of Hematology/Oncology，Kunming Children's Hospital；Department of Hematology/Oncology，Guangzhou Women and Children's Medical Center）.Venous thromboembolism in children with acute lymphoblastic leukemia in China：a report from the Chinese Children's Cancer Group-ALL-2015[J].Frontiers of Medicine,2023,第3期 Fen Zhang¹，Lanlan Xiao¹，Ya Yang¹，Menghao Zhou¹，Yalei Zhao^1,2，Zhongyang Xie¹，Xiaoxi Ouyang¹，Feiyang Ji³，Shima Tang¹，Lanjuan Li¹（State Key Laboratory for Diagnosis and Treatment of Infectious Diseases，National Clinical Research Center for Infectious Diseases，Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases，The First Affiliated Hospital，Zhejiang University School of Medicine；Department of Infectious Diseases，First Affiliated Teaching Hospital，School of Medicine，Xi'an Jiaotong University；Department of Surgical Oncology，Sir Run Run Shaw Hospital，Zhejiang University）.Human menstrual blood-derived stem cells alleviate autoimmune hepatitis via JNK/MAPK signaling pathway in vivo and in vitro[J].Frontiers of Medicine,2023,第3期 You Wang^1,2,3，Sihan Lin^1,2,3，Jiayue Wu^1,2,3，Meng Jiang^1,2,3，Jianhua Lin^1,2,3，Yu Zhang^1,2,3，Huihua Ding⁴，Haibo Zhou⁴，Nan Shen^4,5,6，Wen Di^1,2,3（Department of Obstetrics and Gynaecology，Renji Hospital，School of Medicine，Shanghai Jiao Tong University；Shanghai Key Laboratory of Gynaecologic Oncology；State Key Laboratory of Oncogenes and Related Genes，Shanghai Cancer Institute，Renji Hospital，School of Medicine，Shanghai Jiao Tong University；Shanghai Institute of Rheumatology，Renji Hospital，School of Medicine，Shanghai Jiao Tong University；Center for Autoimmune Genomics and Etiology (CAGE)，Cincinnati Children's Hospital Medical Center；Department of Pediatrics，University of Cincinnati College of Medicine）.Control of lupus activity during pregnancy via the engagement of IgG sialylation：novel crosstalk between IgG sialylation and pDC functions[J].Frontiers of Medicine,2023,第3期 Ying Dong¹，Yingbei Qi^1,2，Haowen Jiang¹，Tian Mi¹，Yunkai Zhang^1,3，Chang Peng^1,3，Wanchen Li^1,3，Yongmei Zhang^1,2，Yubo Zhou^1,4，Yi Zang^1,5,2，Jia Li^1,3,6,2,7（State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences；University of Chinese Academy of Sciences；Zhongshan Institute for Drug Discovery，Shanghai Institute of Materia Medica，Chinese Academy of Sciences；Lingang Laboratory；Open Studio for Druggability Research of Marine Natural Products，Pilot National Laboratory for Marine Science and Technology(Qingdao)；Shandong Laboratory of Yantai Drug Discovery，Bohai Rim Advanced Research Institute for Drug Discovery）.The development and benefits of metformin in various diseases[J].Frontiers of Medicine,2023,第3期 Wencheng Zhang^1,2,3，Yangyang Cui^1,2,3,4，Yuan Du^1,5，Yong Yang^1,5，Ting Fang^1,2,3，Fengfeng Lu^1,2,3，Weixia Kong⁶，Canjun Xiao⁷，Jun Shi^5,7，Lola M.Reid⁸，Zhiying He^1,2,3（Institute for Regenerative Medicine，Ji'an Hospital，Shanghai East Hospital，School of Life Sciences and Technology，Tongji University；Shanghai Engineering Research Center of Stem Cells Translational Medicine；Shanghai Institute of Stem Cell Research and Clinical Translation；Postgraduate Training Base of Shanghai East Hospital，Jinzhou Medical University；The First Affiliated Hospital of Nanchang University；Graduate School of Frontier Biosciences，Osaka University；Department of General Surgery，Ji'an Hospital，Shanghai East Hospital，School of Medicine，Tongji University；Department of Cell Biology and Physiology and Program in Molecular Biology and Biotechnology，UNC School of Medicine）.Liver cell therapies：cellular sources and grafting strategies[J].Frontiers of Medicine,2023,第3期 Hao Wang，Li Liu，Tangchun Wu（Ministry of Education and State Key Laboratory of Environmental Health (Incubating)，School of Public Health，Tongji Medical College，Huazhong University of Science and Technology）.Effectiveness of inactivated COVID-19 vaccine against the severity of Omicron variant[J].Frontiers of Medicine,2023,第3期 Kevin M.Veen¹，Grigorios Papageorgiou²，Casper F.Zijderhand¹，Mostafa M.Mokhles¹，Jasper J.Brugts³，Olivier C.Manintveld³，Alina A.Constantinescu³，Jos A.Bekkers¹，Johanna J.M.Takkenberg¹，Ad J.J.C.Bogers¹，Kadir Caliskan³（Department of Cardiothoracic Surgery，Erasmus MC；Department of Biostatistics，Erasmus MC；Department of Cardiology，Erasmus MC）.The clinical impact of tricuspid regurgitation in patients with a biatrial orthotopic heart transplant[J].Frontiers of Medicine,2023,第3期 Susi Zhu^1,2,3,4,5，Xu Zhang^1,2,3,4，Yeye Guo^1,2,3,4，Ling Tang^1,2,3,4,5，Zhe Zhou^1,2,3,4，Xiang Chen^1,2,3,4，Cong Peng^1,2,3,4（Department of Dermatology，Xiangya Hospital，Central South University；Hunan Key Laboratory of Skin Cancer and Psoriasis；Hunan Engineering Research Center of Skin Health and Disease；National Clinical Research Center for Geriatric Disorders，Xiangya Hospital，Central South University；Department of Clinical Pharmacology，Xiangya Hospital，Central South University）.NETO2 promotes melanoma progression via activation of the Ca²⁺/CaMKII signaling pathway[J].医学前沿,2023,第2期 Xueqing Hu，Ujjwol Khatri，Tao Shen，Jie Wu（Peggy and Charles Stephenson Cancer Center，Department of Pathology，University of Oklahoma Health Sciences Center）.Progress and challenges in RET-targeted cancer therapy[J].医学前沿,2023,第2期 Chang Yifan，Zhao Xianzhi，Xiao Yutian，Yan Shi，Xu Weidong，Wang Ye，Zhang Huojun，Ren Shancheng.Neoadjuvant radiohormonal therapy for oligo-metastatic prostate cancer:safety and efficacy outcomes from an open-label, dose-escalation, single-center, phase I/II clinical trial[J].医学前沿,2023,第2期 Xue Wang^1,2，Ye Zhou³，Junxia Min¹，Fudi Wang^1,2（The Second Affiliated Hospital，The First Affiliated Hospital，Institute of Translational Medicine，School of Public Health，State Key Laboratory of Experimental Hematology，Zhejiang University School of Medicine；The First Affiliated Hospital，Basic Medical Sciences，School of Public Health，Hengyang Medical School，University of South China；Department of Endocrinology and Metabolism，Ningbo First Hospital）.Zooming in and out of ferroptosis in human disease[J].医学前沿,2023,第2期 Fan Yuhua，Zhang Yue，Zhao Hongrui，Liu Wenfeng，Xu Wanqing，Jiang Lintong，Xu Ranchen，Zheng Yue，Tang Xueqing，Li Xiaohan，Zhao Limin，Liu Xin，Hong Yang，Lin Yuan，Chen Hui，Zhang Yong.IncR-GAS5 upregulates the splicing factor SRSF10 to impair endothelial autophagy, leading to atherogenesis[J].医学前沿,2023,第2期 Pengfei Li，Zexuan Chen，Shanshan You，Yintai Xu，Zhifang Hao，Didi Liu，Jiechen Shen，Bojing Zhu，Wei Dan，Shisheng Sun（College of Life Sciences，Northwest University）.Application of StrucGP in medical immunology：site-specific N-glycoproteomic analysis of macrophages[J].医学前沿,2023,第2期首页上一页 1 2 3 下一页尾页共有3页，转到页

期刊文章列表